Sethi is Lead Investigator on Drug Trial with Positive Results

Updated September 7, 2017 This content is archived.

Sanjay Sethi, MD, professor of medicine and chief of the Division of Pulmonary, Critical Care and Sleep Medicine, has led a trial demonstrating a statistically significant improvement in lung function for patients with chronic obstructive pulmonary disease. The results show the improvement is “achieved by the combination of aclidinium and formoterol compared to single LAMA bronchodilators tiotropium and aclidinium, with comparable safety,” he says.